Health
Everest Medicines Announces Taiwan TFDA Approval of NEFECON® for the Treatment of Primary IgA Nephropathy
SHANGHAI , Oct. 21, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announces that the Taiwan Food and Drug Admini...
2024-10-21 07:40
1699
Humavant® 100% Human Milk-Based Fortifiers Helping Premature Infants in Australia Grow and Develop
Human Milk-Based Nutrition Is Clinically Demonstrated to Improve Health Outcomes in Very Low Birth Weight Babies Compared to Cow Milk-Based Products ADELAIDE, Australia, Oct. 21, 2024 /PRNewswire/ -- Prolacta Bioscience®, the world's leading hospital provider of 100% human milk-based nutritional ...
2024-10-21 04:05
1716
Hong Kong Breast Cancer Foundation "Pink Walk 2024" Charity Walk Concluded Successfully
Nearly 2,000 Pink Walkers gathered at The Peak Walk for Breast Health, Together We Can HONG KONG, Oct. 20, 2024 /PRNewswire/ -- The signature annual charity walk, "Pink Walk 2024", organised by Hong Kong Breast Cancer Foundation (HKBCF), was successfully held today at The Peak,Hong Kong Island. ...
2024-10-20 17:23
2041
Curio Digital Therapeutics Applauded by Frost & Sullivan for Enhancing Women's Maternal Mental Healthcare with its MamaLift and MamaLift Plus Solutions
MamaLift ensures personalized care tailored to each woman's journey through motherhood, empowering them to manage stress, embrace joy, and reduce the risk of depression and anxiety during and after pregnancy. SAN ANTONIO, Oct. 19, 2024 /PRNewswire/ -- Frost & Sullivan assessed the women's health...
2024-10-19 23:30
2166
Olight Launches Charity Campaigns in Support of Breast Cancer Awareness and Hurricane Relief
LORTON, Va., Oct. 18, 2024 /PRNewswire/ -- Olight, a brand committed to
becoming a global leader in mid-to-high-end flashlights, introduced its charity
initiatives dedicated to supporting breast cancer awareness and hurricane
disaster relief this October.
2024-10-18 21:31
1785
Xinhua Silk Road: 55th Zhangshu National Traditional Chinese Materia Medica Trade Fair held in E. China's Jiangxi
BEIJING, Oct. 18, 2024 /PRNewswire/ -- The 55th Zhangshu National Traditional Chinese Materia Medica Trade Fair kicked off onOctober 16 in Zhangshu, a county-level city in eastChina's Jiangxi Province, featuring the participation of more than 1,000 pharmaceutical and healthcare enterprises from a...
2024-10-18 20:23
2259
City microbes surviving on disinfectants, research reveals
New research shows microbes are evolving to resist cleaners used to eliminate them. It also identifies novel strains living inHong Kong that were previously only found in Antarctic desert soil. SUZHOU, China, Oct. 18, 2024 /PRNewswire/ -- After the recent pandemic, our use of disinfectants has i...
2024-10-18 17:24
2574
Medeze Group Awarded Frost & Sullivan's 2024 Southeast Asia Company of the Year for Delivering Highly Innovative Stem Cell and Longevity Solutions
Medeze Group (Medeze) specializes in cutting-edge stem cell banking services, leveraging advanced cryopreservation techniques and pioneering therapies to enhance longevity and health outcomes. SAN ANTONIO, Oct. 18, 2024 /PRNewswire/ -- Frost & Sullivan recently researched the stem cell banking a...
2024-10-18 15:00
1373
Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings
GOTHENBURG, Sweden, Oct. 18, 2024 /PRNewswire/ -- "The order intake increased by 10.0%, of which organic growth was 7.4%. All regions reported a positive performance," says Mattias Perjos, President & CEO at Getinge. The medtech company's net sales increased by 3.5%, of which the organic increase...
2024-10-18 14:42
1395
Antengene Announces XPOVIO® (selinexor) Approved for Its Third Indication in South Korea, Bringing Fresh Hope to Patients with MM in the Country
* This approval for XPOVIO® for the treatment of patients with multiple myeloma (MM) marks the third approved indication of the drug inSouth Korea. * To date, XPOVIO® has already been included in national health insurance or reimbursement schemes inSouth Korea, the mainland of China, Australia...
2024-10-18 10:35
2135
Columbia Asia Harnesses Solar Energy for Sustainable Healthcare
Partnership with Solarvest Energy Sdn Bhd Significantly Reduces Carbon Dioxide Emissions Across Nine Hospitals in The Country KUALA LUMPUR, Malaysia, Oct. 18, 2024 /PRNewswire/ -- Columbia Asia, one of Malaysia's largest chain of private hospitals and part of Asia OneHealthcare (A1Health) has of...
2024-10-18 09:00
1844
OmniaBio Announces Opening of New Commercial Manufacturing Facility in Canada, Bringing Life-Saving Cell and Gene Therapies to Patients
The site will add state-of-the-art CGT capacity and employ artificial intelligence and automation to achieve critical product supply efficiencies for North American and global biotherapy clients HAMILTON, ON, Oct. 18, 2024 /PRNewswire/ -- Today OmniaBio Inc. will announce the opening of a new No...
2024-10-18 07:00
1470
Telix Files Form 20-F Registration Statement for Nasdaq ADS
MELBOURNE, Australia, Oct. 18, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces that it has publicly filed a Form 20-F registration statement (Registration Statement) withthe United States (U.S.) Securities and Exchange Commission (SEC) relating to a pro...
2024-10-18 05:32
1782
Press Announcement: AIMed24 Announces Strategic Partnership with Frost & Sullivan
SAN ANTONIO, Oct. 17, 2024 /PRNewswire/ -- AIMed24, the premier event for artificial intelligence and healthcare innovation, is excited to announce its strategic partnership with Frost & Sullivan. This collaboration will further enhance AIMed24's mission to advance healthcare with cutting-edge AI...
2024-10-17 23:01
1365
Telix Q3 2024 Business Update - Quarterly Revenue Exceeds AU$200M
MELBOURNE, Australia, Oct. 17, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on its revenue and operational performance for the quarter ended30 September 2024 (Q3 2024). Revenue update, full year guidance reaffirmed * Unaudited to...
2024-10-17 15:54
1569
AXA Insurance Announces Strategic Name Change of "XL Re China" to "AXA International Re"
Reinforcing brand synergy and expanding reinsurance operations in mainland China HONG KONG, Oct. 17, 2024 /PRNewswire/ -- AXA China Region Insurance Company ( Bermuda) Limited ("AXA Insurance") is pleased to announce the official name change of XL Reinsurance (China) Company Limited ("XL Re China"...
2024-10-17 15:20
1402
Cambrex Opens New Stability Storage Facility in Durham, North Carolina
EAST RUTHERFORD, N.J., Oct. 17, 2024 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced that their stability storage business, Q1 Scientific, has opened a new cGMP facility inDurham, North Carolina, expanding its capacity for envi...
2024-10-17 15:00
1343
CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
Temporary marketing authorization is based on statistically significant and clinically meaningful results from the phase-III PROTECT trial ST. GALLEN, Switzerland and SAN DIEGO, Oct. 17, 2024 /PRNewswire/ -- CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that Swissmedic...
2024-10-17 14:30
2976
Bio X Cell Announces Board of Director Appointments
A Leading Producer of Monoclonal Antibodies LEBANON, N.H., Oct. 17, 2024 /PRNewswire/ -- Bio X Cell, LLC ("BXC" or the "Company"), the world's leading producer of monoclonal antibodies for pre-clinicalin vivo research applications, is pleased to announce the appointments ofAlan Hirzel and Kevin ...
2024-10-17 14:00
1207
IND Application for a Phase Ⅲ Clinical Study of KN026 Combined with Albumin-bound Docetaxel as Neoadjuvant Treatment for Breast Cancer was Approved
SUZHOU, China, Oct. 17, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966 HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (stock code: 1093.HK) jointly announced that an application for a phase III clinical study (Study ID: KN026-004) of the anti-HER2 bispecific antibody KN026 combine...
2024-10-17 10:15
1712
Week's Top Stories
Most Reposted
Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 305 media titles]
2024-11-20 13:29Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 303 media titles]
2024-11-21 10:30Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 299 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Oxygen, HubSpot's leading solutions partner in Hong Kong & Greater China Expands to UAE
[Picked up by 296 media titles]
2024-11-15 15:25
Most Read
Oxygen, HubSpot's leading solutions partner in Hong Kong & Greater China Expands to UAE
2024-11-15 15:25
8683
How "small apples" march into "big industry" in Yan'an
2024-11-15 17:39
5536
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5116
Yingli Solar's Global Product Workshops Launched in Malaysia
2024-11-15 21:40
4753
